Literature DB >> 28369802

Direct-acting antivirals for hepatitis C virus induce a rapid clinical and biochemical remission of porphyria cutanea tarda.

A Combalia1, J To-Figueras2, M Laguno3, M Martínez-Rebollar3, P Aguilera1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28369802     DOI： 10.1111/bjd.15502

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  5 in total

Review 1.  Heme biosynthesis and the porphyrias.

Authors:  John D Phillips
Journal:  Mol Genet Metab       Date:  2019-04-22       Impact factor: 4.797

Review 2.  [Porphyrias-what is verified?]

Authors:  U Stölzel; I Kubisch; T Stauch
Journal:  Internist (Berl)       Date:  2018-12       Impact factor: 0.743

3.  A Case-Based Review of Iron Overload With an Emphasis on Porphyria Cutanea Tarda, Hepatitis C, C282Y Heterozygosity, and Coronary Artery Disease.

Authors:  Leila Hashemi; Robert Nisenbaum
Journal:  Fed Pract       Date:  2020-02

4.  Disappearance of multiple hyperechoic liver nodules in sporadic porphyria cutanea tarda after treatment with ledipasvir/sofosbuvir for hepatitis C.

Authors:  Kazuhide Takata; Satoshi Shakado; Keiko Sakamoto; Hiromi Fukuda; Ryo Yamauchi; Sho Fukuda; Hideo Kunimoto; Kaoru Umeda; Takashi Tanaka; Keiji Yokoyama; Daisuke Morihara; Yasuaki Takeyama; Makoto Irie; Shotaro Sakisaka
Journal:  Clin J Gastroenterol       Date:  2017-09-07

5.  Three cases of incident lichen planus after direct-acting antiviral treatment for hepatitis C.

Authors:  Meredith Steuer; Anthony Maher; Erin Amerson
Journal:  JAAD Case Rep       Date:  2018-11-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.